Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A4 | P31645 | 10/20 | 0.50 |
| ▸ | MAOA | P21397 | 1/20 | 0.50 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | GSK3B | P49841 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 2/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | DDAH1 | O94760 | 1/20 | 0.35 |
| ▸ | NOS1 | P29475 | 1/20 | 0.35 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.34 |
| ▸ | CA12 | O43570 | 1/20 | 0.34 |
| ▸ | CA1 | P00915 | 1/20 | 0.34 |
| ▸ | CA2 | P00918 | 1/20 | 0.34 |
| ▸ | CA7 | P43166 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL346860 | 0.91 | SLC6A4 (0.56) | SLC6A4MAOAMAPK1GSK3BRAB9A | |
| SCHEMBL8591154 | 0.82 | SLC6A4 (0.50) | SLC6A4MAOAMAPK1GSK3BHPGD | |
| SCHEMBL9793575 | 0.82 | SLC6A4 (0.50) | SLC6A4MAOAGSK3BLMNARAB9A | |
| SCHEMBL169195 | 0.80 | SLC6A4 (0.48) | SLC6A4MAOALMNAHPGDRAB9A | |
| SCHEMBL13940796 | 0.80 | SLC6A4 (0.48) | SLC6A4MAOA | |
| SCHEMBL22068902 | 0.78 | ALDH1A1 (0.41) | SLC6A4MAOARAB9ANPC1 | |
| SCHEMBL19454683 | 0.78 | SLC6A4 (0.52) | SLC6A4MAOAGSK3BRAB9ANPC1 | |
| SCHEMBL4523181 | 0.78 | SLC6A4 (0.52) | SLC6A4MAOACYP3A4TSHRMAPK1 | |
| SCHEMBL3371540 | 0.78 | NR1H2 (0.50) | SLC6A4MAOANR1H2CYP3A4TSHR | |
| SCHEMBL96478 | 0.78 | SLC6A4 (0.47) | SLC6A4MAOAMAPK1GSK3BRAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230242568-A1 | POLYMER LINKED MULTIMERS OF GUANOSINE-3', 5'-CYCLIC MONOPHOSPHATES | MIRECA MEDICINES GMBH (DE) | 2023-08-03 | — | — | US | disclosed |
| US-20210317156-A1 | NEW POLYMER LINKED MULTIMERS OF GUANOSINE-3', 5'-CYCLIC MONOPHOSPHATES | MIRECA MEDICINES GMBH (DE) | 2021-10-14 | — | — | US | disclosed |
| US-8648146-B2 | Activated solid support and method | GE HEALTHCARE BIO-SCIENCES AB (SE) | 2014-02-11 | — | — | US | disclosed |
| US-8648146-B2 | Activated solid support and method | GE HEALTHCARE BIO-SCIENCES AB (SE) | 2014-02-11 | — | — | US | disclosed |
| US-20120245301-A1 | ACTIVATED SOLID SUPPORT AND METHOD | GE HEALTHCARE BIO-SCIENCES AB (SE) | 2012-09-27 | — | — | US | disclosed |
| US-20120245301-A1 | ACTIVATED SOLID SUPPORT AND METHOD | GE HEALTHCARE BIO-SCIENCES AB (SE) | 2012-09-27 | — | — | US | disclosed |
| US-8217118-B2 | Activated solid support and method | GE HEALTHCARE BIO-SCIENCES AB (SE) | 2012-07-10 | — | — | US | disclosed |
| US-8217118-B2 | Activated solid support and method | GE HEALTHCARE BIO-SCIENCES AB (SE) | 2012-07-10 | — | — | US | disclosed |
| US-20090048456-A1 | ACTIVATED SOLID SUPPORT AND METHOD | GE HEALTHCARE BIO-SCIENCES AB (SE) | 2009-02-19 | — | — | US | disclosed |
| US-20090048456-A1 | ACTIVATED SOLID SUPPORT AND METHOD | GE HEALTHCARE BIO-SCIENCES AB (SE) | 2009-02-19 | — | — | US | disclosed |
| WO-2007062768-A2 | ACTIVATED SOLID SUPPORT AND METHOD | GE HEALTHCARE BIO-SCIENCES AB (SE) | 2007-06-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230242568-A1 | POLYMER LINKED MULTIMERS OF GUANOSINE-3', 5'-CYCLIC MONOPHOSPHATES | PRKG1, PRKG2, PRKAG3 | SLC6A4 4047/4885MAOA 1533/4885NR1H2 4823/4885 |
| US-20120245301-A1 | ACTIVATED SOLID SUPPORT AND METHOD | OSTC, HLCS, SPR | SLC6A4 2165/4885MAOA 357/4885NR1H2 944/4885 |
| US-20210317156-A1 | NEW POLYMER LINKED MULTIMERS OF GUANOSINE-3', 5'-CYCLIC MONOPHOSPHATES | PRKG1, PRKG2, PDE7A | SLC6A4 4340/4885MAOA 1734/4885NR1H2 4839/4885 |
| US-20090048456-A1 | ACTIVATED SOLID SUPPORT AND METHOD | OSTC, HLCS, SPR | SLC6A4 2165/4885MAOA 357/4885NR1H2 944/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.